Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3VO Medical is a private, early-stage medical device company focused on obstetric care and childbirth intervention. The company is developing a minimally invasive intrauterine labor augmentation system intended to improve labor contractions and manage prolonged labor or dystocia during Stage I active labor. Its lead product has been described as an Intrauterine Labor Enhancement System/Intrauterine Labor Augmentation System delivered through a catheter-based approach. The goal is to reduce maternal and fetal risk, shorten abnormally prolonged labor, and potentially lower cesarean-section rates. The company has received U.S. SBIR funding to advance feasibility work and appears to remain an active California corporation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3VO Medical.